Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
ConditionGastric Adenocarcinoma
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
This phase I finds out the possible benefits and/or side effects of using magnetic tracer FerroTrace and the fluorescent dye indocyanine green to identify the lymph nodes that cancer is most likely to have spread to in patients with gastric cancer that are undergoing gastrectomy. Using FerroTrace in combination with the indocyanine green dye may help researchers better detect the disease.
Eligibility criteria
Qualifiers
Age 18 or older
Willing to provide informed consent
Biopsy proven gastric cancer, undergoing curative-intent gastrectomy
No distant metastases
Disqualifiers
Contraindications to surgery +/- adjuvant therapy
Allergy or intolerance to iron oxide compounds
Allergy or intolerance to iodides
Iron overload disorder
Trial design
Treatments tested in this trial
- Gastrectomy
- Indocyanine Green
- Iron Conjugated Polymers in Saline Suspension
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov